Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study
Journal of Pharmaceutical Health Services Research, EarlyView.
Source: Journal of Pharmaceutical Health Services Research - Category: Drugs & Pharmacology Authors: Zainab Jassim
,
Reem Elajez
,
Imran Khudair
,
Rasha Al Anany
,
Rana Moustafa Al ‐Adawi Source Type: research
More News: Byetta | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Middle East Health | Qatar Health | Study | Victoza